Clinical Research Directory
Browse clinical research sites, groups, and studies.
INSPIRIS China PMCF Study
Sponsor: Edwards Lifesciences
Summary
The objective of this post-market trial is to evaluate long term safety and performance of the Edwards Lifesciences INSPIRIS RESILIA aortic valve in Chinese patients in a real-world clinical setting.
Official title: Post-Market Clinical Follow-up Study of Edwards Lifesciences INSPIRIS RESILIA Aortic Valve in Chinese Population
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
255
Start Date
2022-07-13
Completion Date
2029-12
Last Updated
2026-03-25
Healthy Volunteers
No
Conditions
Interventions
EDWARDS INSPIRIS RESILIA Aortic Valve
Surgical replacement of the aortic valve with the INSPIRIS RESILIA Aortic Valve.
Locations (13)
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Hefei, Anhui, China
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Fuwai Hospital, CAMS & PUMC
Beijing, Beijing Municipality, China
Xiamen Cardiovascular Hospital Xiamen University
Xiamen, Fujian, China
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen
Shenzhen, Guangdong, China
Henan Provincial Chest Hospital
Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Fuwai Central China Cardiovascular Hospital
Zhengzhou, Henan, China
Nanjing First Hospital
Nanjing, Jiangsu, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China
Sichuan Academy of Medical Sciences·Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Fuwai Yunnan Cardiovascular Hospital
Kunming, Yunnan, China